Stock Alerts on Today’s Market Movers: AIS, SLM, LVLT, XEL, LPL, JNPR
Featuring AIS’ FDA approval; SLM’s analyst upgrade; LVLT’s network expansion; XEL’s Q2 results schedule; LPL’s LCD line investment; JNPR’s new application offering.
(EMAILWIRE.COM, July 01, 2009 ) DALLAS, Texas – InvestorSoup.com announces the release of Stock Alerts covering Tuesday’s market movers: Antares Pharma Inc. (AMEX: AIS), SLM Corp. (NYSE: SLM), Level 3 Communications Inc. (Nasdaq: LVLT), Xcel Energy Inc. (NYSE: XEL), LG Display Co., Ltd (NYSE: LPL) and Juniper Networks Inc. (Nasdaq: JNPR).
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at http://www.investorsoup.com.
In the Stock Alerts, the author highlights FDA’s approval of Antares-Teva needle free injection system:
“Antares Pharma Inc. (AMEX: AIS) shares jumped on word that U.S. health regulators have approved the use of the human growth hormone Tev-Tropin in a needle-free injection system. With this approval, Teva's already approved drug can be used in Antares' system, which does not involve a syringe injection. The companies will market the device as the Tev-Tropin Tjet Injector system. … Antares-Teva partnership addresses the approximately $1 billion U.S. market for human growth hormone, according to industry estimates, benefiting pediatric patients by offering avoidance of using needles as well as the rapid injection speed associated with giving needle-free injections. … Israel-based Teva has been marketing the human growth hormone as a regular injection since 2005. The ‘needle-free injection’ initiative took root last year when the two companies filed for a supplemental new drug application.”
The Stock Alerts author also featured a bump in SLM’s price estimate from FBR Capital Markets:
“Shares of SLM Corp. (NYSE: SLM) (Sallie Mae) were lifted yesterday after FBR Capital Markets upped the stock's price estimate. In a research note, the analyst, seeing a boost in earnings, said the student lender's stock should rise as it services a big chunk of government-originated loans to college students. Report has it that the student lender is among four companies to share in servicing, but not originating, a total $550 million in outstanding federal student loans and future loans owned by the government. Sallie Mae is engaged in the business to originate, service and collect student loans. … Keeping an Outperform rating, analyst Matthew Snowling lifted his 12-month target for Reston, Va.-based Sallie Mae to $16 from $13. … In addition, Snowling said Sallie Mae's stock is poised to benefit from easing investor concerns about its access to cash, and reduced capital demands.”
Investors can view all of the Stock Alerts and investment articles for free by visiting:
http://www.investorsoup.com
Join the fastest growing investor community at:
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at http://www.investorsoup.com.
In the Stock Alerts, the author highlights FDA’s approval of Antares-Teva needle free injection system:
“Antares Pharma Inc. (AMEX: AIS) shares jumped on word that U.S. health regulators have approved the use of the human growth hormone Tev-Tropin in a needle-free injection system. With this approval, Teva's already approved drug can be used in Antares' system, which does not involve a syringe injection. The companies will market the device as the Tev-Tropin Tjet Injector system. … Antares-Teva partnership addresses the approximately $1 billion U.S. market for human growth hormone, according to industry estimates, benefiting pediatric patients by offering avoidance of using needles as well as the rapid injection speed associated with giving needle-free injections. … Israel-based Teva has been marketing the human growth hormone as a regular injection since 2005. The ‘needle-free injection’ initiative took root last year when the two companies filed for a supplemental new drug application.”
The Stock Alerts author also featured a bump in SLM’s price estimate from FBR Capital Markets:
“Shares of SLM Corp. (NYSE: SLM) (Sallie Mae) were lifted yesterday after FBR Capital Markets upped the stock's price estimate. In a research note, the analyst, seeing a boost in earnings, said the student lender's stock should rise as it services a big chunk of government-originated loans to college students. Report has it that the student lender is among four companies to share in servicing, but not originating, a total $550 million in outstanding federal student loans and future loans owned by the government. Sallie Mae is engaged in the business to originate, service and collect student loans. … Keeping an Outperform rating, analyst Matthew Snowling lifted his 12-month target for Reston, Va.-based Sallie Mae to $16 from $13. … In addition, Snowling said Sallie Mae's stock is poised to benefit from easing investor concerns about its access to cash, and reduced capital demands.”
Investors can view all of the Stock Alerts and investment articles for free by visiting:
http://www.investorsoup.com
Join the fastest growing investor community at:
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
|
How to buy Penny Stocks
Learn the Skills, Make the Trades, Earn a Fortune! 100% Free to try. Chartpoppers.com Stop Being Fooled By "Penny Stock Picks" Subscribe To The #1 Rated MicroCap Stock Newsletter. MicroCapster.com Analyst Penny Stock Picks Visit StockSource.us for explosive stock picks, free stock research and trading tools www.StockSource.us Your text Ads here! Ads are only $575 per month. Ads are placed same day. Contac Us Emailwire.com/contact.php |